Identification and validation of a four-miRNA ( miRNA-21-5 p , miRNA-9-5 p , miR-1495 p , and miRNA-30 b-5 p ) prognosis signature in clear cell renal cell carcinoma

php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Cancer Management and Research 2018:10 5759–5766 Cancer Management and Research Dovepress